Our data confirm a strong trend toward studies using human induced PSCs (iPSCs), while human embryonic stem cells (ESCs) continue to be used in a significant portion of roughly 50% of all studies.
← all excerpts
History and current status of clinical studies using human pluripotent stem cells.
1
—
—